California Public Employees Retirement System Exelixis, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

A detailed history of California Public Employees Retirement System transactions in Exelixis, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 1,392,425 shares of EXEL stock, worth $46.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,392,425

Previous 1,464,672 4.93%

Holding current value

$46.9 Million

Previous $32.9 Million 9.79%

% of portfolio

0.03%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $1.59 Million - $1.99 Million	-72,247 Reduced 4.93%	1,392,425 $36.1 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $9.58 Million - $11.2 Million	-471,150 Reduced 24.34%	1,464,672 $32.9 Million
Q1 2024 Apr 30, 2024	SELL	$20.17 - $23.93 $775,919 - $920,563	-38,469 Reduced 1.95%	1,935,822 $45.9 Million
Q4 2023 Feb 01, 2024	BUY	$19.25 - $24.13 $3.91 Million - $4.9 Million	203,163 Added 11.47%	1,974,291 $47.4 Million
Q3 2023 Nov 02, 2023	BUY	$19.04 - $22.74 $10 Million - $12 Million	526,814 Added 42.34%	1,771,128 $38.7 Million
Q2 2023 Aug 09, 2023	BUY	$18.17 - $20.48 $3.25 Million - $3.66 Million	178,688 Added 16.77%	1,244,314 $23.8 Million
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $175,599 - $209,103	-10,773 Reduced 1.0%	1,065,626 $20.7 Million
Q4 2022 Feb 08, 2023	BUY	$14.96 - $17.39 $4.99 Million - $5.8 Million	333,555 Added 44.9%	1,076,399 $17.3 Million
Q3 2022 Nov 09, 2022	BUY	$15.68 - $22.27 $2.31 Million - $3.29 Million	147,558 Added 24.79%	742,844 $11.6 Million
Q2 2022 Aug 10, 2022	SELL	$17.44 - $23.16 $223,092 - $296,262	-12,792 Reduced 2.1%	595,286 $12.4 Million
Q1 2022 May 04, 2022	SELL	$17.03 - $22.67 $830,927 - $1.11 Million	-48,792 Reduced 7.43%	608,078 $13.8 Million
Q4 2021 Feb 10, 2022	SELL	$15.84 - $21.88 $597,912 - $825,904	-37,747 Reduced 5.43%	656,870 $12 Million
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $13,088 - $16,975	-803 Reduced 0.12%	694,617 $14.7 Million
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $535,861 - $763,042	-29,853 Reduced 4.12%	695,420 $12.7 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $593,645 - $729,261	-28,916 Reduced 3.83%	725,273 $16.4 Million
Q4 2020 Feb 02, 2021	BUY	$18.39 - $24.8 $1.01 Million - $1.36 Million	54,657 Added 7.81%	754,189 $15.1 Million
Q3 2020 Nov 05, 2020	BUY	$20.67 - $26.94 $379,335 - $494,402	18,352 Added 2.69%	699,532 $17.1 Million
Q2 2020 Aug 12, 2020	BUY	$16.46 - $27.42 $168,978 - $281,493	10,266 Added 1.53%	681,180 $16.2 Million
Q1 2020 May 12, 2020	SELL	$14.46 - $21.8 $638,495 - $962,600	-44,156 Reduced 6.18%	670,914 $11.6 Million
Q4 2019 Jan 27, 2020	BUY	$15.15 - $18.89 $608,742 - $759,019	40,181 Added 5.95%	715,070 $12.6 Million
Q3 2019 Oct 31, 2019	BUY	$17.68 - $22.65 $3.74 Million - $4.79 Million	211,697 Added 45.7%	674,889 $11.9 Million
Q2 2019 Aug 15, 2019	BUY	$18.93 - $24.75 $661,149 - $864,418	34,926 Added 8.16%	463,192 $9.9 Million
Q1 2019 May 03, 2019	BUY	$19.6 - $24.76 $275,928 - $348,571	14,078 Added 3.4%	428,266 $10.2 Million
Q4 2018 Feb 08, 2019	SELL	$13.65 - $21.8 $465,628 - $743,641	-34,112 Reduced 7.61%	414,188 $8.15 Million
Q3 2018 Nov 13, 2018	SELL	$15.87 - $22.4 $782,232 - $1.1 Million	-49,290 Reduced 9.91%	448,300 $7.94 Million
Q2 2018 Aug 15, 2018	SELL	$18.56 - $22.45 $2.84 Million - $3.44 Million	-153,113 Reduced 23.53%	497,590 $10.7 Million
Q1 2018 May 11, 2018	SELL	$22.15 - $31.89 $974,644 - $1.4 Million	-44,002 Reduced 6.33%	650,703 $14.4 Million
Q4 2017 Feb 06, 2018	BUY	$24.23 - $30.93 $755,152 - $963,964	31,166 Added 4.7%	694,705 $21.1 Million
Q3 2017 Nov 15, 2017	BUY	$23.35 - $29.24 $15.5 Million - $19.4 Million	663,539	663,539 $16.1 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.8B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Exelixis, Inc. Transaction History